Medicare to negotiate price of Ozempic, Wegovy weight-loss drugs

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

View original article
Contributor: Dan Diamond, Rachel Roubein, Daniel Gilbert